12:00 AM
May 28, 2007
 |  BioCentury  |  Finance

Amgen's balance sheet shuffle

Amgen's balance sheet shuffle

Last week, Amgen (AMGN) sold $4 billion in notes, saying it plans to use $3 billion of the proceeds to buy back shares. In December 2006, the company's board authorized the repurchase of up to $5 billion worth of shares. At the end of December, with a share price of $68.31, AMGN could have...

Read the full 261 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >